Daiwa Securities Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.58M | Buy |
104,839
+4,265
| +4% | +$297K | 0.02% | 402 |
|
|
2025
Q4 | $6.67M | Buy |
100,574
+4,767
| +5% | +$308K | 0.02% | 392 |
|
|
2025
Q3 | $6.45M | Buy |
95,807
+51
| +0.1% | +$4.04K | 0.02% | 393 |
|
|
2025
Q2 | $8.36M | Sell |
95,756
-652
| -0.7% | -$51.1K | 0.03% | 313 |
|
|
2025
Q1 | $6.58M | Buy |
96,408
+15,429
| +19% | +$1.26M | 0.03% | 342 |
|
|
2024
Q4 | $6.3M | Buy |
80,979
+3,880
| +5% | +$287K | 0.03% | 339 |
|
|
2024
Q3 | $5.17M | Buy |
77,099
+490
| +0.6% | +$40.2K | 0.02% | 371 |
|
|
2024
Q2 | $8.69M | Buy |
76,609
+15,109
| +25% | +$1.91M | 0.05% | 220 |
|
|
2024
Q1 | $8.53M | Buy |
61,500
+4,775
| +8% | +$600K | 0.05% | 217 |
|
|
2023
Q4 | $7.04M | Buy |
56,725
+2,339
| +4% | +$239K | 0.04% | 225 |
|
|
2023
Q3 | $5.07M | Buy |
54,386
+5,219
| +11% | +$588K | 0.04% | 275 |
|
|
2023
Q2 | $6.32M | Sell |
49,167
-470
| -0.9% | -$56.8K | 0.04% | 229 |
|
|
2023
Q1 | $5.77M | Sell |
49,637
-2,526
| -5% | -$283K | 0.04% | 239 |
|
|
2022
Q4 | $5.91M | Sell |
52,163
-1,348
| -3% | -$148K | 0.05% | 230 |
|
|
2022
Q3 | $4.31M | Buy |
53,511
+3,286
| +7% | +$278K | 0.04% | 274 |
|
|
2022
Q2 | $3.74M | Buy |
50,225
+3,661
| +8% | +$334K | 0.03% | 307 |
|
|
2022
Q1 | $5.96M | Buy |
46,564
+9,896
| +27% | +$1.08M | 0.04% | 247 |
|
|
2021
Q4 | $4.92M | Buy |
36,668
+3,708
| +11% | +$533K | 0.03% | 293 |
|
|
2021
Q3 | $4.51M | Buy |
32,960
+4,180
| +15% | +$527K | 0.03% | 284 |
|
|
2021
Q2 | $3.07M | Buy |
28,780
+1,772
| +7% | +$170K | 0.02% | 339 |
|
|
2021
Q1 | $2.43M | Buy |
27,008
+3,024
| +13% | +$284K | 0.02% | 364 |
|
|
2020
Q4 | $2.22M | Sell |
23,984
-52,236
| -69% | -$4.66M | 0.02% | 366 |
|
|
2020
Q3 | $7.86M | Buy |
76,220
+9,664
| +15% | +$1.01M | 0.07% | 122 |
|
|
2020
Q2 | $4.48M | Hold |
66,556
| – | – | 0.09% | 114 |
|
|
2020
Q1 | $4.48M | Buy |
66,556
+51,068
| +330% | +$3.18M | 0.05% | 176 |
|
|
2019
Q4 | $847K | Buy |
15,488
+1,928
| +14% | +$91.4K | 0.01% | 577 |
|
|
2019
Q3 | $506K | Buy |
13,560
+160
| +1% | +$6.22K | ﹤0.01% | 668 |
|
|
2019
Q2 | $502K | Hold |
13,400
| – | – | ﹤0.01% | 659 |
|
|
2019
Q1 | $399K | Hold |
13,400
| – | – | ﹤0.01% | 709 |
|
|
2018
Q4 | $401K | Sell |
13,400
-27,124
| -67% | -$860K | ﹤0.01% | 660 |
|
|
2018
Q3 | $1.45M | Sell |
40,524
-65,328
| -62% | -$2.03M | 0.01% | 434 |
|
|
2018
Q2 | $2.51M | Sell |
105,852
-85,632
| -45% | -$1.82M | 0.02% | 339 |
|
|
2018
Q1 | $3.55M | Buy |
191,484
+2,004
| +1% | +$29.6K | 0.03% | 285 |
|
|
2017
Q4 | $2.72M | Buy |
189,480
+180,280
| +1,960% | +$2.34M | 0.02% | 332 |
|
|
2017
Q3 | $113K | Hold |
9,200
| – | – | ﹤0.01% | 893 |
|
|
2017
Q2 | $168K | Hold |
9,200
| – | – | ﹤0.01% | 837 |
|
|
2017
Q1 | $195K | Buy |
9,200
+7,600
| +475% | +$148K | ﹤0.01% | 787 |
|
|
2016
Q4 | $24K | Buy |
+1,600
| New | +$28.3K | ﹤0.01% | 1004 |
|
Other funds holding DXCM
VCM
VPM
Daiwa Securities Group's DXCM Position: Q1 2026 in Review
Daiwa Securities Group increased its DexCom (DXCM) stake by 4.2% in Q1 2026, buying an estimated $297K and bringing the position to 104,839 shares worth $6.58M. The position accounts for 0.02% of the portfolio, ranked #402.
Daiwa Securities Group first reported a position in DXCM in Q4 2016 and has held it in 38 quarters since. The position peaked at $8.69M in Q2 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Daiwa Securities Group held 104,839 shares of DexCom worth $6.58M as of Q1 2026.
- Daiwa Securities Group bought 4,265 DexCom shares in Q1 2026, an estimated $297K.
- DexCom made up 0.02% of Daiwa Securities Group's portfolio in Q1 2026, its #402 holding.
- Daiwa Securities Group first reported a position in DexCom in Q4 2016 and has held it in 38 quarters since.
- Daiwa Securities Group's DexCom position peaked at $8.69M in Q2 2024.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.